Industry news

• By 2030, Russia aims to produce 90% of essential medicines

  09 December 2024 GxP news

  Within the framework of the national project “New Technologies for Saving Health”, it is planned to significantly increase the production of critically important medicines in Russia. As noted by the Prime Minister of the Russian Federation Mikhail Mishustin during a meeting of the Council on National Projects, by 2030 it is planned to increase the share of domestic production of vital drugs from the list of vital and essential drugs to 90%.

• The government allocated more funds for preferential loans on imported medicines and medical devices

  06 December 2024 GxP news

  The government allocated over 5 billion rubles for preferential lending to buy priority imported products. Launched in late 2022, this initiative offers affordable financing for essential foreign products. The list includes drugs containing insulin, antibiotics, various types of medical devices and other medical goods.

• RNC Pharma: Russians’ spending on medicines has reached a historic high

  06 December 2024 GxP news

  RNC Pharma reports that in October 2024, Russians’ total expenditure on pharmaceuticals reached an unprecedented 151.6 billion rubles, marking a new historical high. From January to October, the retail pharmaceutical market volume was 1.33 trillion rubles, a 16.6% increase from 2023. The main growth factor was the increase in drug prices, but the increase in household income also stimulated the transition to more expensive drugs.

• The government announced a new national project “Bioeconomics”

  05 December 2024 GxP news

  Large-scale government initiatives to develop key sectors of the Russian economy are expected soon. Russian Prime Minister Mikhail Mishustin announced that project implementation will start in early 2025 after review by the Presidential Council for Strategic Development.

• The Ministry of Health has drafted a new mechanism for supplying drugs to orphan patients

  05 December 2024 GxP news

  The Russian Ministry of Health is drafting an amendment to Federal Law to enhance medicine provision for adult patients with orphan diseases. The document states that if the regional budget lacks sufficient funds, the responsibility for provision will fall on the federal budget.

• RNC Pharma: Russians’ spending on medicines has reached a historic high

  04 December 2024 GxP news

  RNC Pharma reports that in October 2024, Russians’ total expenditure on pharmaceuticals reached an unprecedented 151.6 billion rubles, marking a new historical high. From January to October, the retail pharmaceutical market volume was 1.33 trillion rubles, a 16.6% increase from 2023. The main growth factor was the increase in drug prices, but the increase in household income also stimulated the transition to more expensive drugs.

• Most life sciences CEOs expect to grow their head counts over the next 3 years: KPMG survey

  04 December 2024 Kevin Dunleavy / Fierce Biotech

  On a routine basis in recent years, headlines about layoffs in the biopharma industry have surfaced as companies large and small have been cutting costs and restructuring. Over the last 10 days, for example, Fierce has written about dismissals at Bristol Myers Squibb, Novartis, Lexicon Pharmaceuticals, Johnson & Johnson, Gilead Sciences, Merck, Sonata Therapeutics, Medigene and Alector Therapeutics.

• Russia to conduct an experiment on monitoring dietary supplement manufacturers

  03 December 2024 GxP news

  Russia will launch a pilot project on March 1, 2025, to monitor labeled goods manufacturers, including dietary supplements. The key objective of the project is to create an effective system for verifying data on products and their manufacturers. A methodology will be developed for analyzing information and monitoring mechanisms, along with testing access restrictions to marking codes when violations occur. Particular attention is paid to creating a system for pre-trial appeal of operator decisions by manufacturers.

• Sustainable analytical approach devised for complex drug formulation

  03 December 2024 Catherine Eckford / European Pharmaceutical Review

  The innovative method uses spectroscopy and could enhance pharmaceutical quality assurance in resource-limited settings, the study suggests.

• Branches of Russian medical universities are planned to be opened in Kazakhstan

  02 December 2024 GxP news

  Russian Health Minister Mikhail Murashko engaged in discussions with Tamara Duseinova, the Deputy Prime Minister of Kazakhstan, and Akmaral Alnazarova, the country’s Health Minister. During the meeting, key issues of cooperation between the countries in the field of healthcare were discussed.